Zosano Pharma Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zosano Pharma in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Zosano Pharma stock.
View analyst ratings for Zosano Pharma or view top-rated stocks.

Wall Street analysts have given Zosano Pharma a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Zosano Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Zosano Pharma is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Zosano Pharma.

Zosano Pharma Co. (NASDAQ:ZSAN) issued its earnings results on Wednesday, May, 12th. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.08). The biotechnology company had revenue of $0.26 million for the quarter.
View Zosano Pharma's earnings history.

Zosano Pharma's stock was trading at $0.5662 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ZSAN shares have increased by 41.7% and is now trading at $0.8021.
View which stocks have been most impacted by COVID-19.

Zosano Pharma shares reverse split before market open on Friday, January 26th 2018. The 1-20 reverse split was announced on Thursday, January 25th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 25th 2018. An investor that had 100 shares of Zosano Pharma stock prior to the reverse split would have 5 shares after the split.

3 Wall Street analysts have issued 12 month price targets for Zosano Pharma's shares. Their forecasts range from $2.00 to $2.50. On average, they expect Zosano Pharma's stock price to reach $2.17 in the next year. This suggests a possible upside of 170.1% from the stock's current price.
View analysts' price targets for Zosano Pharma or view top-rated stocks among Wall Street analysts.

Some companies that are related to Zosano Pharma include Verona Pharma (VRNA), Altimmune (ALT), Athersys (ATHX), Neoleukin Therapeutics (NLTX), DURECT (DRRX), Oncorus (ONCR), Theratechnologies (THTX), Cue Biopharma (CUE), Aerovate Therapeutics (AVTE), Tonix Pharmaceuticals (TNXP), Aeglea BioTherapeutics (AGLE), RedHill Biopharma (RDHL), UroGen Pharma (URGN), Angion Biomedica (ANGN) and Flexion Therapeutics (FLXN).
View all of ZSAN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Zosano Pharma investors own include Aeterna Zentaris (AEZS), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Cannabics Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Novan (NOVN), Hallador Energy (HNRG) and EnLink Midstream (ENLC).

(ZSAN) raised $47 million in an initial public offering on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

Zosano Pharma trades on the NASDAQ under the ticker symbol "ZSAN."

Shares of ZSAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ZSAN stock can currently be purchased for approximately $0.80.

Zosano Pharma has a market capitalization of $85.61 million and generates $220,000.00 in revenue each year. The biotechnology company earns $-33,370,000.00 in net income (profit) each year or ($0.49) on an earnings per share basis.

Zosano Pharma employs 45 workers across the globe.

The official website for Zosano Pharma is www.zosanopharma.com.

Zosano Pharma is headquartered at 34790 ARDENTECH COURT, FREMONT CA, 94555.

Zosano Pharma's mailing address is 34790 ARDENTECH COURT, FREMONT CA, 94555. The biotechnology company can be reached via phone at 510-745-1200 or via email at [email protected]